Clear Harbor Asset Management’s Pfizer PFE Stock Holding History

Clear Harbor Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$265K	–	436
2024 Q4	$265K	Buy	+10,000	New	+$271K	0.02%	324
2024 Q3	–	Sell	-11,500	Closed	-$322K	–	392
2024 Q2	$322K	Buy	+11,500	New	+$317K	0.03%	282
2024 Q1	–	Sell	-5,000	Closed	-$144K	–	394
2023 Q4	$144K	Buy	+5,000	New	+$151K	0.01%	340

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Clear Harbor Asset Management's PFE Position: Q1 2026 in Review

Clear Harbor Asset Management increased its Pfizer (PFE) stake by 23% in Q1 2026, buying an estimated $721K and bringing the position to 146,263 shares worth $4.11M. The position accounts for 0.28% of the portfolio, ranked #77.

Clear Harbor Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.92M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Clear Harbor Asset Management held 146,263 shares of Pfizer worth $4.11M as of Q1 2026.
Clear Harbor Asset Management bought 27,096 Pfizer shares in Q1 2026, an estimated $721K.
Pfizer made up 0.28% of Clear Harbor Asset Management's portfolio in Q1 2026, its #77 holding.
Clear Harbor Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Clear Harbor Asset Management's Pfizer position peaked at $4.92M in Q1 2015.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.